1. Home
  2. COCO vs DYN Comparison

COCO vs DYN Comparison

Compare COCO & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Vita Coco Company Inc.

COCO

The Vita Coco Company Inc.

HOLD

Current Price

$53.77

Market Cap

3.0B

ML Signal

HOLD

DYN

Dyne Therapeutics Inc.

HOLD

Current Price

$18.83

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COCO
DYN
Founded
2004
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Medicinal Chemicals and Botanical Products
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.0B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
COCO
DYN
Price
$53.77
$18.83
Analyst Decision
Buy
Strong Buy
Analyst Count
9
14
Target Price
$58.13
$37.00
AVG Volume (30 Days)
1.1M
2.2M
Earning Date
04-29-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
26.60
N/A
EPS
1.19
N/A
Revenue
N/A
N/A
Revenue This Year
$16.12
N/A
Revenue Next Year
$11.40
N/A
P/E Ratio
$46.02
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.79
$7.01
52 Week High
$61.39
$25.00

Technical Indicators

Market Signals
Indicator
COCO
DYN
Relative Strength Index (RSI) 46.20 58.28
Support Level $50.40 $18.32
Resistance Level $55.43 $20.08
Average True Range (ATR) 2.49 1.18
MACD -0.31 0.10
Stochastic Oscillator 32.98 76.48

Price Performance

Historical Comparison
COCO
DYN

About COCO The Vita Coco Company Inc.

The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever & Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. The company has two segments: The Americas segment which comprises of operations in the U.S. and Canada; and The International segment that comprises of operations in Europe, the Middle East, Africa and the Asia Pacific regions. The Americas segment derives maximum revenue. Geographical presence of the company is in United States, United Kingdom and All other countries.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: